Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES DR. REDDYS LAB DIVIS LABORATORIES/
DR. REDDYS LAB
 
P/E (TTM) x 31.0 20.7 149.6% View Chart
P/BV x 6.3 3.9 161.8% View Chart
Dividend Yield % 1.1 0.7 160.2%  

Financials

 DIVIS LABORATORIES   DR. REDDYS LAB
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
DR. REDDYS LAB
Mar-22
DIVIS LABORATORIES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs5,4255,614 96.6%   
Low Rs3,5623,655 97.5%   
Sales per share (Unadj.) Rs337.51,294.6 26.1%  
Earnings per share (Unadj.) Rs111.5126.9 87.9%  
Cash flow per share (Unadj.) Rs123.3196.9 62.6%  
Dividends per share (Unadj.) Rs30.0030.00 100.0%  
Avg Dividend yield %0.70.6 103.1%  
Book value per share (Unadj.) Rs441.81,145.8 38.6%  
Shares outstanding (eoy) m265.47166.43 159.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.33.6 371.9%   
Avg P/E ratio x40.336.5 110.3%  
P/CF ratio (eoy) x36.523.5 154.9%  
Price / Book Value ratio x10.24.0 251.5%  
Dividend payout %26.923.6 113.8%   
Avg Mkt Cap Rs m1,192,890771,272 154.7%   
No. of employees `000NANA-   
Total wages/salary Rs m9,46238,858 24.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,598215,452 41.6%  
Other income Rs m1,1594,847 23.9%   
Total revenues Rs m90,757220,299 41.2%   
Gross profit Rs m38,81137,674 103.0%  
Depreciation Rs m3,11511,652 26.7%   
Interest Rs m20958 2.1%   
Profit before tax Rs m36,83529,911 123.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2318,789 82.3%   
Profit after tax Rs m29,60521,122 140.2%  
Gross profit margin %43.317.5 247.7%  
Effective tax rate %19.629.4 66.8%   
Net profit margin %33.09.8 337.0%  
BALANCE SHEET DATA
Current assets Rs m96,104177,880 54.0%   
Current liabilities Rs m24,54497,658 25.1%   
Net working cap to sales %79.937.2 214.5%  
Current ratio x3.91.8 215.0%  
Inventory Days Days956 15.6%  
Debtors Days Days987113 873.0%  
Net fixed assets Rs m50,087106,819 46.9%   
Share capital Rs m531832 63.8%   
"Free" reserves Rs m116,751189,859 61.5%   
Net worth Rs m117,282190,691 61.5%   
Long term debt Rs m05,746 0.0%   
Total assets Rs m146,191284,699 51.3%  
Interest coverage x1,842.832.2 5,718.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.8 81.0%   
Return on assets %20.37.8 261.3%  
Return on equity %25.211.1 227.9%  
Return on capital %31.415.7 200.0%  
Exports to sales %047.1 0.0%   
Imports to sales %19.718.8 105.2%   
Exports (fob) Rs mNA101,544 0.0%   
Imports (cif) Rs m17,67640,401 43.8%   
Fx inflow Rs m78,445101,544 77.3%   
Fx outflow Rs m17,95340,401 44.4%   
Net fx Rs m60,49261,143 98.9%   
CASH FLOW
From Operations Rs m19,11828,108 68.0%  
From Investments Rs m-21,949-26,387 83.2%  
From Financial Activity Rs m-5,324-2,422 219.8%  
Net Cashflow Rs m-8,15632 -25,486.3%  

Share Holding

Indian Promoters % 51.9 26.7 194.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 35.8 50.7 70.7%  
FIIs % 15.2 27.3 55.5%  
ADR/GDR % 0.0 10.5 -  
Free float % 48.1 62.8 76.6%  
Shareholders   414,847 246,788 168.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    CIPLA    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Divis Laboratories vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Dr. Reddys Share Price Performance

Period Divis Laboratories Dr. Reddys S&P BSE HEALTHCARE
1-Day 1.86% 1.00% 1.20%
1-Month -19.05% 3.54% -3.18%
1-Year -34.48% 3.84% -7.59%
3-Year CAGR 10.28% 12.50% 16.43%
5-Year CAGR 22.18% 15.54% 9.40%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 26.9%.

Dr. Reddys paid Rs 30.0, and its dividend payout ratio stood at 23.6%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15% Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15%(Closing)

After opening the day on a positive note, Indian share markets continued their momentum as the session progressed and ended higher.